Adjuvant Chemotherapy Combined With Targeted Therapy or Not in the T3-4N2 Colorectal Cancer Patients
Status:
Not yet recruiting
Trial end date:
2033-04-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial] is to compare in resectable stage T3-4N2 colorectal cancer.
The main question it aims to answer is: whether the use of targeted therapy in combination
with adjuvant chemotherapy is associated with improved disease-free survival (DFS) compared
to adjuvant chemotherapy alone.